Skip to main content

Table 1 Clinical characteristics of the study population

From: Echocardiographic characteristics of PRKAG2 syndrome: a research using three-dimensional speckle tracking echocardiography compared with sarcomeric hypertrophic cardiomyopathy

Variable

PRKAG2

Healthy

HCM

P1

P2

Age, years

40.22 ± 14.01

42.04 ± 14.86

49.59 ± 12.75

0.719

0.056

Male/female

5/4

68/134

28/13

0.281

0.467

BSA, m2

1.74 ± 0.20

1.65 ± 0.19

1.78 ± 0.21

0.199

0.627

BMI, kg/m2

23.80 ± 2.77

23.39 ± 3.88

25.45 ± 3.54

0.771

0.256

HR, bpm

53.11 ± 10.14

69.22 ± 10.48

67.23 ± 10.32

 < 0.001

0.001

  1. P1: P values between the PRKAG2 group and the healthy volunteers, P2: P values between the PRKAG2 group and the sarcomeric HCM group. BSA Body surface area, BMI Body mass index, HR heart rate
Back to article page

Cardiovascular Ultrasound

ISSN: 1476-7120

Contact us